about
Implementation of Enhanced Recovery After Surgery: a strategy to transform surgical care across a health system.Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.Enhanced recovery pathways in gynecologic oncology.Compression sutures for uterine atony and hemorrhage following cesarean delivery.Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis.Cost impact analysis of Enhanced Recovery After Surgery program implementation in Alberta colon cancer patients.An economic evaluation of the Enhanced Recovery After Surgery (ERAS) multisite implementation program for colorectal surgery in AlbertaUterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors.The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer.Implementation and validation of a combined MRI-CT-based cervical cancer brachytherapy program using existing infrastructure.Patients as partners in Enhanced Recovery After Surgery: A qualitative patient-led study.Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study.Immunohistochemical Profiling of Endometrial Serous Carcinoma.Implementation of Enhanced Recovery After Surgery (ERAS) Across a Provincial Healthcare System: The ERAS Alberta Colorectal Surgery Experience.Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC).Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.Molecular alterations in indolent, aggressive and recurrent ovarian low-grade serous carcinoma.Time to surgery and the risk of cancer progression in patients with gynaecologic cancers of the lower genital tract.Architectural patterns of ovarian/pelvic high-grade serous carcinoma.PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study.Primary squamous cell carcinoma of the endometrium: clinicopathologic and molecular characteristics.Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part II.Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part I.ERAS-Value based surgery.The Canadian Gynaecologic Oncology Perioperative Management Survey: Baseline Practice Prior to Implementation of Enhanced Recovery After Surgery (ERAS) Society Guidelines.Enhancement of contrast echocardiography by image variability analysis.POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.A 2D finite element model of the interventricular septum under normal and abnormal loadingQuantitation of basal dyssynchrony and acute resynchronization from left or biventricular pacing by novel echo-contrast variability imagingPrimary carcinoma of the rectovaginal septum diagnosed as uterine prolapseControversy in colposcopic management: a Canadian surveyPrecursor lesions and prognostic factors in primary peritoneal serous carcinomaThe importance of surgical staging in women with uterine serous carcinoma: experience in a single institution reveals a survival benefitEnhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service: A Randomized Controlled TrialEnhanced recovery in gynecologic oncology - A sea change in perioperative managementEnhanced recovery after surgery (ERAS®) in gynecologic oncology - Practical considerations for program development
P50
Q33709148-D05C7F9A-BAA2-474B-9765-C372ED263678Q34687073-5CEBAB2D-A611-456D-BFEF-49E2A1B0621CQ35332962-26378922-8D2C-4D5B-BD06-5A28F67C4969Q36352505-376BBB88-F300-4C1C-ADE7-807818816DF8Q36629514-45868C46-B0C8-4E49-87D0-AF258F49EE2EQ36989124-FAFCDF80-79C7-4827-93B5-48F5D0C84D4FQ37446708-E1C0F6FB-970E-4A41-B6CB-6EF3EF17AB33Q38022182-63547763-3499-4360-B155-FD26D02E64EFQ38096241-FF6FE195-BB36-4C53-B3A3-C13D1CD628F3Q38150122-743EB2E4-E959-45D2-8505-A9BF5F529B69Q38380219-09D42116-D02D-4752-B867-41FD4D550484Q38557327-DBC04F37-76F8-4C72-96EE-387D2834FEA9Q38881939-357BD077-5434-4234-8EFC-6769DF2D7DFCQ39775470-25F364AF-1606-4AE8-B317-E89356DCE26CQ39958160-0E92C5AB-2821-48ED-90F8-1E66F2CD5DD3Q40015533-F8B0B526-4B90-4BD0-A40D-D8C0DDEFBD40Q40559275-D562B328-EE64-42A5-94BE-A83212BE725CQ40602149-554E41EF-2AAE-4976-980B-E7C8A275ABBAQ40910629-EDC92343-675A-41E3-96FC-507E6E8E3A1EQ43770336-04676923-8EBD-487A-BF7E-3FE163B61122Q44448363-E2985B8D-6DF0-4C5F-AEE1-28C58BC36E04Q45049293-D4AA234D-419B-4D90-8D3E-1E8DFF83A396Q45811461-16FA6265-ABD9-4270-AD7D-1EE513F5BE17Q47604835-396638F4-B79D-4433-ABD5-443355F0744CQ47623420-E70BA85C-61FF-42E5-B19D-1BBBF8D78DDAQ48126791-C1F8D702-E355-4A82-AAF9-C1156D72C915Q51327404-9A7B9F6C-7101-4E64-81B8-85BC137C473FQ52051862-CE516974-65A7-495F-BB3E-EB0ACA4347C3Q54351302-DBF1B894-A096-4E68-A4DC-6FFE0EBA4BC6Q73819513-72CD5BC4-63A9-43F2-8474-EA3F162F9790Q74363839-D8C3FC01-A5BB-461D-B4B1-2CEECF6EE51CQ82789225-98494717-D05F-4639-B5E3-832C1DA0B469Q82807043-6C2EFB37-AEB4-411B-868B-D6BC53898ABCQ86046480-E30FB042-5407-4ADD-9311-776D699A0529Q86702474-8B63F22F-A0EC-491E-9CC4-B5C0764F6587Q88137516-61357E4B-9E92-42DF-8FA6-C1E040FF4ACDQ88378864-DA9EEB05-3892-40F6-A27B-DEA361DB75AAQ89071151-DC8516B3-3795-47E5-AB50-256FBA8BEE9D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gregg Nelson
@ast
Gregg Nelson
@en
Gregg Nelson
@es
Gregg Nelson
@nl
type
label
Gregg Nelson
@ast
Gregg Nelson
@en
Gregg Nelson
@es
Gregg Nelson
@nl
prefLabel
Gregg Nelson
@ast
Gregg Nelson
@en
Gregg Nelson
@es
Gregg Nelson
@nl
P106
P1153
7402779740
P31
P496
0000-0002-8177-1098